Newsfeeds - Spark Newswire

1 minute read

Earnings

Recap: Amedisys Q2 Earnings

Today, 9:15 AM

Amedisys (NASDAQ:AMED) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amedisys beat estimated earnings by 19.51%, reporting an EPS of $1.47 versus an estimate of $1.23.

AMED

18 minute read

Earnings Scheduled For July 27, 2022

By Benzinga Insights

Today, 9:15 AM

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.

ACGL

1 minute read

Truist Securities Maintains Buy on Amedisys, Lowers Price Target to $150

By Benzinga Newsdesk

Today, 9:15 AM

Truist Securities analyst David Macdonald maintains Amedisys (NASDAQ:AMED) with a Buy and lowers the price target from $175 to $150.

AMED

5 minute read

67 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:15 AM

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

ACAD

3 minute read

45 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 9:15 AM

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.

ACAD

1 minute read

B of A Securities Downgrades Amedisys to Underperform, Lowers Price Target to $102

By Benzinga Newsdesk

Today, 9:15 AM

B of A Securities analyst Joanna Gajuk downgrades Amedisys (NASDAQ:AMED) from Neutral to Underperform and lowers the price target from $145 to $102.

AMED

1 minute read

Deutsche Bank Maintains Buy on Amedisys, Lowers Price Target to $175

By Benzinga Newsdesk

Today, 9:15 AM

Deutsche Bank analyst Justin Bowers maintains Amedisys (NASDAQ:AMED) with a Buy and lowers the price target from $210 to $175.

AMED

1 minute read

10 Biggest Price Target Changes For Tuesday

By Lisa Levin

Today, 9:15 AM

Goldman Sachs cut SunPower Corporation. (NASDAQ: SPWR) price target from $19 to $13. SunPower shares fell 3.1% to $17.37 in pre-market trading.

ACAD

1 minute read

SVB Leerink Maintains Market Perform on Amedisys, Lowers Price Target to $107

By Benzinga Newsdesk

Today, 9:15 AM

SVB Leerink analyst Whit Mayo maintains Amedisys (NASDAQ:AMED) with a Market Perform and lowers the price target from $117 to $107.

AMED

1 minute read

Analyst Ratings

Analyst Ratings for Amedisys

By Benzinga Insights

Today, 9:15 AM

Over the past 3 months, 5 analysts have published their opinion on Amedisys (NASDAQ:AMED) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

AMED